Rein Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Rein Therapeutics, Inc. (RNTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 402.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 402.00K shares.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 87.50K shares, a 100.57% increase year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 87.50K shares, a 92.85% decline from fiscal 2024.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.22M shares, a 11125.46% increase from fiscal 2023.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 10.90K shares, a 93.09% decline from fiscal 2022.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 157.79K shares, a 97.06% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 402.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 402.00K shares 10-Q · filed 2026-08-14 | 402.00K shares derived: sum of 3 quarters · filed 2026-08-14 | 489.50K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-15 | 87.50K shares derived: sum of 3 quarters · filed 2026-05-15 | 87.50K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 87.50K shares derived: sum of 2 quarters · filed 2026-03-26 | 87.50K shares derived: sum of 3 quarters · filed 2026-03-26 | 87.50K shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 87.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 87.50K shares derived: sum of 2 quarters · filed 2025-11-14 | 87.50K shares 10-Q · filed 2025-11-14 | 1.06M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | 974.50K shares derived: sum of 3 quarters · filed 2026-05-15 | 1.02M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 974.50K shares derived: sum of 2 quarters · filed 2026-05-15 | 1.02M shares derived: sum of 3 quarters · filed 2026-05-15 | 1.22M shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | 974.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | 1.02M shares derived: sum of 2 quarters · filed 2025-04-07 | 1.22M shares derived: sum of 3 quarters · filed 2025-04-07 | 1.22M shares 10-K · filed 2025-04-07 |
| 2024-09-30 | 43.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 243.63K shares derived: sum of 2 quarters · filed 2024-11-14 | 249.07K shares 10-Q · filed 2024-11-14 | 259.98K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 200.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 205.45K shares 10-Q · filed 2024-08-14 | 216.35K shares derived: sum of 3 quarters · filed 2024-08-14 | 216.35K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | 5.45K shares 10-Q · filed 2024-05-15 | 16.35K shares derived: sum of 2 quarters · filed 2024-05-15 | 16.35K shares derived: sum of 3 quarters · filed 2024-11-14 | 16.35K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | 10.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | 10.90K shares derived: sum of 2 quarters · filed 2024-11-14 | 10.90K shares derived: sum of 3 quarters · filed 2024-11-14 | 10.90K shares 10-K · filed 2024-04-15 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 0.00 shares 10-Q · filed 2024-11-14 | -2.99M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 0.00 shares 10-Q · filed 2024-08-14 | -2.99M shares derived: sum of 3 quarters · filed 2024-08-14 | -2.99M shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | -2.99M shares derived: sum of 2 quarters · filed 2024-05-15 | -2.99M shares derived: sum of 3 quarters · filed 2024-05-15 | -2.42M shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -2.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -2.99M shares derived: sum of 2 quarters · filed 2023-03-20 | -2.42M shares derived: sum of 3 quarters · filed 2023-03-20 | 157.79K shares 10-K · filed 2023-03-20 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 566.50K shares derived: sum of 2 quarters · filed 2022-11-01 | 3.15M shares 10-Q · filed 2022-11-01 | 3.15M shares derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | 566.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 3.15M shares 10-Q · filed 2022-08-15 | 3.15M shares derived: sum of 3 quarters · filed 2022-08-15 | 3.15M shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 2.58M shares 10-Q · filed 2022-05-05 | 2.58M shares derived: sum of 2 quarters · filed 2022-05-05 | 2.59M shares derived: sum of 3 quarters · filed 2022-05-05 | 7.83M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 5.70K shares derived: sum of 2 quarters · filed 2022-03-28 | 5.25M shares derived: sum of 3 quarters · filed 2022-03-28 | 5.37M shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 5.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 5.25M shares derived: sum of 2 quarters · filed 2021-11-12 | 5.37M shares 10-Q · filed 2021-11-12 | 5.42M shares derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 5.24M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 5.37M shares 10-Q · filed 2021-08-11 | 5.42M shares derived: sum of 3 quarters · filed 2021-08-11 | 5.42M shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | 122.40K shares 10-Q · filed 2021-05-11 | 172.40K shares derived: sum of 2 quarters · filed 2021-05-11 | 172.40K shares derived: sum of 3 quarters · filed 2021-05-11 | 408.40K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | 50.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 50.00K shares derived: sum of 2 quarters · filed 2021-03-24 | 286.00K shares derived: sum of 3 quarters · filed 2021-03-24 | 1.82M shares 10-K · filed 2021-03-24 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 236.00K shares derived: sum of 2 quarters · filed 2020-11-12 | 1.77M shares 10-Q · filed 2020-11-12 | 1.77M shares derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-06-30 | 236.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | 1.77M shares 10-Q · filed 2020-08-05 | 1.77M shares derived: sum of 3 quarters · filed 2020-08-05 | 1.77M shares derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | 1.53M shares 10-Q · filed 2020-05-11 | 1.53M shares derived: sum of 2 quarters · filed 2020-05-11 | 1.53M shares derived: sum of 3 quarters · filed 2020-05-11 | 3.13M shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2020-03-30 | 1.59M shares derived: sum of 3 quarters · filed 2020-03-30 | 1.69M shares 10-K · filed 2020-03-30 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 1.59M shares derived: sum of 2 quarters · filed 2019-11-07 | 1.69M shares 10-Q · filed 2019-11-07 | 2.08M shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 1.59M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 1.69M shares 10-Q · filed 2019-08-06 | 2.08M shares derived: sum of 3 quarters · filed 2019-08-06 | 2.37M shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 100.00K shares 10-Q · filed 2019-05-08 | 492.50K shares derived: sum of 2 quarters · filed 2019-05-08 | 776.91K shares derived: sum of 3 quarters · filed 2019-05-08 | 937.91K shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 392.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 676.91K shares derived: sum of 2 quarters · filed 2019-03-29 | 837.91K shares derived: sum of 3 quarters · filed 2019-03-29 | 947.91K shares 10-K · filed 2019-03-29 |
| 2018-09-30 | 284.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 445.41K shares derived: sum of 2 quarters · filed 2018-11-07 | 555.41K shares 10-Q · filed 2018-11-07 | 601.41K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 161.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 271.00K shares 10-Q · filed 2018-08-07 | 317.00K shares derived: sum of 3 quarters · filed 2018-08-07 | 936.03K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 110.00K shares 10-Q · filed 2018-05-09 | 156.00K shares derived: sum of 2 quarters · filed 2018-05-09 | 775.03K shares derived: sum of 3 quarters · filed 2018-05-09 | |
| 2017-12-31 | 46.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 665.03K shares derived: sum of 2 quarters · filed 2018-04-02 | 1.25M shares 10-K · filed 2018-04-02 | |
| 2017-09-30 | 619.03K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 1.21M shares 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 588.70K shares 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |